New York City pledged this week to pay down $2 billion worth of residents’ medical debt. In doing so, it has come around to an innovation, started in the Midwest, that’s ridding millions of Americans of health care debt.
Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition
Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models.